Amber L. Mosley
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
200
Citations
4,509
Est. group size
~2
Recurring co-author estimate
Active years
25
Publishing since 2002
Amber L. Mosley studies how proteins and RNA are modified, degraded, and regulated inside cells, often using mass spectrometry-based proteomics (large-scale measurement of proteins). Recent work spans the immunoproteasome (a protein-recycling machine linked to immune recognition) in cancer, protein modifications during neuronal development, and applications in diseases such as Alzheimer's, myeloma, and osteosarcoma. The research frequently involves collaboration across multiple biomedical projects that share common proteomic and molecular-biology methods.
Publication activity has grown over the past decade, rising from a handful per year around 2017 to roughly 20 or more per year recently.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Current awards run through May 2030 — about 4 years of funding on record from today. Awards are often renewed, so this is what is currently public, not a forecast.
Data & Analytics Core
Proteomics Core
Thermal proteome profiling for analysis of protein sequence variants in human genetic disease
2 earlier awards
- NIH R01GM099714Aug 2012 – Apr 2023 · $431k awarded
Regulation of RNA Polymerase II transcription by the phosphatase Rtr1
- NSF 1515748Aug 2015 – Jul 2018 · $660k awarded
Quantitative Analysis of Transcription Elongation Perturbation Networks
Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.
Typically publishes in teams of ~8 · 2% small-team papers (≤3 authors) · across 52 venues
- Characterization of Lysine Methylation During Neuronal Differentiation of LUHMES cells
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- A CAMKK2-UBR4-19S Proteasome Axis Regulates Chondrocyte Proteostasis and SOX9 Stability
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Figure S4 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity
2026
- Figure S5 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity
2026
- Figure S7 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity
2026
- Figure S9 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity
2026
- Supplementary Table 2 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity
2026
- Figure S1 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity
2026
- Figure S3 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity
2026
- Figure S8 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity
2026
- Supplementary Table 1 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity
2026
- Figure S2 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity
2026
- Supplementary Table 4 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity
2026
- Figure S6 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity
2026
- Supplementary Table 3 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity
2026
- bioRxiv (Cold Spring Harbor Laboratory)×25
- Cancer Research×9
- Journal of Biological Chemistry×5
- PMC×5
- Alzheimer s & Dementia×4
- Guoming Gao
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Guramrit Singh
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Caleb M. Embree
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- David J. Elliott
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Lauren A. Woodward
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile